All News about Takeda Pharmaceutical Ltd ADR
![](https://mms.businesswire.com/media/20221213005639/en/1663235/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/09/logo_dark__c424d3ab0271f3cf1e0eea9f187b0781.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221209005038/en/822613/5/takeda_logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/takeda.png?width=1200&height=800&fit=crop)
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/10/27/takeda.png?width=1200&height=800&fit=crop)
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20221208005204/en/834514/4/takeda_logo.jpg)
![](https://www.acnnewswire.com/images/company/astarA.jpg)
![](https://g.foolcdn.com/editorial/images/710651/laboratory-space.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19488.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/05/aapharma_4.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/11/Stock-arrowheadpharma-01-adobe.jpg)
![](https://mms.businesswire.com/media/20221122005793/en/1645538/5/takeda-logo_FULL.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/screenshot_2022-11-22_at_7.24.03_pm.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710337/a-scientist-uses-a-pipette-to-work-with-medical-samples.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/17/1600x900.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221117005280/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://g.foolcdn.com/editorial/images/709201/people-reviewing-financials-on-a-screen.jpg)
![](https://mms.businesswire.com/media/20221110006142/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
Via Business Wire
![](https://g.foolcdn.com/editorial/images/707488/gettyimages-1014182354.jpg)
![](https://mms.businesswire.com/media/20221026005235/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://investorplace.com/wp-content/uploads/2020/11/dividends-1600.jpg)
![](https://www.investors.com/wp-content/uploads/2022/10/A1MAIN_GeneEdit_102122.jpg)
![](https://mms.businesswire.com/media/20221020005133/en/1607471/4/Dr_Falk_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9009.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704944/businessman-showing-chart-to-co-worker.jpg)
![](https://mms.businesswire.com/media/20221013006022/en/834514/4/takeda_logo.jpg)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease
October 05, 2022
Topics
Cannabis
Exposures
Cannabis
![](https://mms.businesswire.com/media/20221004006135/en/694986/4/3472696_BrandSymbol_Dakiyama_Rd.jpg)
![](https://mms.businesswire.com/media/20220929005059/en/1585737/5/Dakiyama_2021_Takeda_Red_DIGITAL_USE.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.